Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
93 pending office actions • 47 art units • 89 examiners • 0 of 93 (0%) have an AI response strategy ready • 99 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 11 (12%) |
| §103 only | 21 (23%) |
| §102 only | 7 (8%) |
| §112 only | 4 (4%) |
| Double-patenting only | 3 (3%) |
| Double-patenting + other | 11 (12%) |
| Multi-statute (no §101) | 32 (34%) |
| No statute on record | 2 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FOX, ALLISON M | 2 | 71.2% | +35.7% |
| NGUYEN, QUANG | 2 | 37.9% | +52.7% |
| BEHARRY, ZANNA MARIA | 2 | 25.0% | +56.3% |
| MACCAGNO, PIERRE L | 2 | 24.3% | +30.8% |
| ROBLES, EILEEN | 1 | — | — |
| ALBERS, KEVIN S | 1 | 26.4% | +49.9% |
| APONTE, MIRAYDA ARLENE | 1 | 63.2% | +20.9% |
| OLAMIT, JUSTIN N | 1 | 62.0% | +9.4% |
| JAFFRI, ZEHRA | 1 | 58.0% | +49.1% |
| MOSHER, ERIC PARKER | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17047967 | MITOCHONDRIAL RNA IMPORT FOR TREATING MITOCHONDRIAL DISEASE | VYAS, KEYUR ANILKUMAR | 87d overdue |
| 17917873 | Microneedle Array Delivery of Adenovirus Vectored Vaccines With and Without Adjuvants | FREDRICKSON, COURTNEY B | 45d overdue |
| 17930854 | MACHINE LEARNING TECHNIQUES FOR DETECTING REDUCED BLOOD FLOW CONDITIONS | OGLES, MATTHEW ERIC | 10d overdue |
| 17927548 | Adenovirus-Based SARS-CoV-2 Vaccine | ALLEN, MICHAEL D | 3d overdue |
| 18013951 | Electrochemical Biosensors for Rapid and Sensitive Detection of Pathogens and Pathogenic Biomarkers | KAUR, GURPREET | 7d |
| 17410360 | PROBIOTICS AND PROBIOTIC COMPOSITIONS HAVING MODIFIED CARBOHYDRATE METABOLISM | CRUM, MARY ABOU NADER | 12d |
| 17756398 | THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS | BEHARRY, ZANNA MARIA | 22d |
| 18879640 | DEVICES, SYSTEMS, AND METHODS FOR PATIENT POSITIONING AND MAINTAINING UPPER AIRWAY PATENCY | ALBERS, KEVIN S | 23d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17756398 | THYMUS ORGANOIDS BIOENGINEERED FROM HUMAN PLURIPOTENT STEM CELLS | BEHARRY, ZANNA MARIA | 22d |
| 18879640 | DEVICES, SYSTEMS, AND METHODS FOR PATIENT POSITIONING AND MAINTAINING UPPER AIRWAY PATENCY | ALBERS, KEVIN S | 23d |
| 17769886 | COMPOSITIONS AND METHODS FOR TREATING LIVER DISEASE | NGUYEN, QUANG | 49d |
| 18878637 | MAXILLO-MANDIBULAR MEASUREMENT TOOL | APONTE, MIRAYDA ARLENE | — |
| 18937726 | DEVICES, SYSTEMS AND METHODS FOR VESSEL LIGATION | JAFFRI, ZEHRA | — |
| 18753253 | BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF | FOX, ALLISON M | — |
| 18286847 | HSV AMPLICON PACKAGING SYSTEM USING ENGINEERED CELLS | NGUYEN, QUANG | — |
| 18316001 | Artificial Cells and Delivery Devices for Use in Tissue Engineering, and Related Methods | FOX, ALLISON M | — |
| Art Unit | Apps |
|---|---|
| 3771 | 4 |
| 1658 | 3 |
| 1632 | 3 |
| 1600 | 3 |
| 3772 | 2 |
| 1612 | 2 |
| 3792 | 2 |
| 1628 | 2 |
| 1633 | 2 |
| 1631 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19037151 | MODIFICATION OF TISSUE PROPERTIES VIA PHOTOMODULATION | ROBLES, EILEEN | — | §102§103§112 | Non-Final OA | — | Pending | Jan 25, 2025 |
| 18879640 | DEVICES, SYSTEMS, AND METHODS FOR PATIENT POSITIONING AND MAINTAINING UPPER AIRWAY PATENCY | ALBERS, KEVIN S | 3786 | §103§112 | Final Rejection | 23d | Pending | Dec 27, 2024 |
| 18878637 | MAXILLO-MANDIBULAR MEASUREMENT TOOL | APONTE, MIRAYDA ARLENE | 3772 | §102 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18983967 | SENSORS WITH DEHUMIDIFIERS | OLAMIT, JUSTIN N | — | §102§103§112Other | Non-Final OA | — | Pending | Dec 17, 2024 |
| 18937726 | DEVICES, SYSTEMS AND METHODS FOR VESSEL LIGATION | JAFFRI, ZEHRA | 3771 | §102§103§112 | Final Rejection | — | Pending | Nov 05, 2024 |
| 18925158 | Perfluorocarbon-Containing Contrast Agent for Use in MRI Imaging of Body Cavities | MOSHER, ERIC PARKER | — | §103§112 | Non-Final OA | — | Pending | Oct 24, 2024 |
| 18909078 | Powered Wheelchair For Vocational Activities | NEYZARI, OMID | — | §102§103 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18851534 | ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY TO RETINAL CELLS | SPENCE, JENNIFER SUZANNE | — | §101§102§103§112DP | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18847735 | Heparanase Inhibition for Graft Protection | DRISCOLL, LORA E BARNHART | — | §102§112 | Non-Final OA | — | Pending | Sep 17, 2024 |
| 18776731 | Decellularization and Functionalization of Extracellular Matrix Biomaterials | FAN, LYNN Y | — | §101§102§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18726764 | GLUCAGON PROMOTER FOR DIABETES GENE THERAPY | TIWARI, VYOMA SHUBHAM | — | §102Other | Non-Final OA | — | Pending | Jul 03, 2024 |
| 18758804 | SELECTIVE PEPTIDOMIMETIC MODULATORS OF CAV2.2 (N-TYPE) VOLTAGE-GATED CALCIUM CHANNELS AND USES THEREOF | KOSACK, JOSEPH R | — | §102 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18753253 | BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF | FOX, ALLISON M | — | §102§103§112DP | Non-Final OA | — | Pending | Jun 25, 2024 |
| 18710080 | POLYMER-BASED GEL IMPLANT FOR RETINAL THERAPY AND METHODS OF MAKING AND USING THE SAME | PACKARD, BENJAMIN J | 1612 | §102§103Other | Non-Final OA | — | Pending | May 14, 2024 |
| 18655945 | ELECTROMAGNETIC SYSTEM FOR RAPID CANNULATION OF FENESTRATED ENDOVASCULAR GRAFTS | RESTAINO, ANDREW PETER | 3771 | §103 | Final Rejection | — | Pending | May 06, 2024 |
| 18655896 | Methods for Preparation of a Terminally Sterilized Hydrogel Derived from Extracellular Matrix | PAGUIO FRISING, MICHELLE F | 1651 | §101DP | Non-Final OA | — | Pending | May 06, 2024 |
| 18706615 | MEDIUM CHAIN DICARBOXYLIC ACIDS FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS | KUCKLA, ANNA GRACE | — | §102§112 | Non-Final OA | — | Pending | May 01, 2024 |
| 18703946 | MOLECULES THAT BIND TO CD94/NKG2A HETERODIMER POLYPEPTIDES | HADDAD, MAHER M | — | §102§112 | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18700913 | Sacral Neuromodulation for Bowel and Sexual Functions | WEBSTER, KARMEL JOHANNA | 3792 | §103 | Non-Final OA | — | Pending | Apr 12, 2024 |
| 18631595 | Glutamate receptor agonists for suppression of mast cell function | CORNET, JEAN P | 1628 | §103§112 | Non-Final OA | — | Pending | Apr 10, 2024 |
| 18699807 | NOVEL TWO ELECTRODE-BASED CORRECTION APPROACH FOR ELIMINATION OF BIOFOULING FROM LABEL-FREE AFFINITY BIOSENSORS FOR DETECTION | SVEIVEN, MICHAEL CAMERON | — | §103§112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18698968 | ALDH Inhibitors to Promote Immune Cell Expansion | REDWOOD, CHRISTOPHER EVAN | — | §102§103§112DP | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18624989 | COMBINATION TREATMENT FOR SOLID TUMORS INCLUDING A STING AGONIST AND A CCR2 ANTAGONIST | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18694219 | IMPLANTABLE CRANIAL ELECTRONICS | EVANISKO, GEORGE ROBERT | 3792 | §102§103§112 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18690454 | NON-FUNGIBLE TOKEN SYSTEM FOR ENSURING ETHICAL, EFFICIENT AND EFFECTIVE MANAGEMENT OF BIOSPECIMENS | CELANI, NICHOLAS P | 2449 | §103 | Non-Final OA | 45d overdue | Pending | Mar 08, 2024 |
| 18682031 | SELECTIVE PSYCHEDELIC COMPOUNDS | SHAMEEM, GOLAM M | 1621 | §102 | Non-Final OA | — | Pending | Feb 07, 2024 |
| 18290705 | GRADIENT CROSS-LINKED POLYMER WITH TRIGGERABLE DECOMPOSITION INTO BENIGN BYPRODUCTS AND METHODS OF USING THE SAME | BOYKIN, TERRESSA M | — | §103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18580741 | MCT11 ANTIBODIES TO TREAT T CELL FUNCTIONAL EXHAUSTION AND ENHANCE CANCER IMMUNOTHERAPY | JUEDES, AMY E | — | §102§103§112 | Final Rejection | — | Pending | Jan 19, 2024 |
| 18580805 | MAGNESIUM MESH WITH FEATURES DESIGNED TO BIOABSORB PROGRESSIVELY TO IMPROVE DENTAL BONE REGENERATION | NELSON, MATTHEW M | 3772 | §102 | Final Rejection | 22d | Pending | Jan 19, 2024 |
| 18578660 | DEVICES AND METHODS FOR CONVEYING NEURON SIGNALS TO A PROCESSING DEVICE | ANTISKAY, BRIAN MICHAEL | 3794 | §103 | Final Rejection | 14d | Pending | Jan 11, 2024 |
| 18515076 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | JONES, DAMERON LEVEST | 1618 | DP | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18287791 | SMAD2 INHIBITION IN BETA CELLS FOR TYPE 2 DIABETES THERAPY | PRONZATI, GINA | 1633 | §102§103§112 | Non-Final OA | — | Pending | Oct 20, 2023 |
| 18286847 | HSV AMPLICON PACKAGING SYSTEM USING ENGINEERED CELLS | NGUYEN, QUANG | 1631 | §103DP | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18480928 | AUGMENTATION OF GAS EXCHANGE BY AN ACOUSTICALLY OSCILLATING MEMBRANE | CHATRATHI, ARJUNA P | 3781 | §103 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18282099 | ALKENE QUINONE COMPOUNDS AND METHODS OF USE | MOU, LIYUAN | 1628 | §103§112 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18461955 | MODIFIED POLYNUCLEOTIDES ENCODING THE SARS-COV-2 SPIKE PROTEIN FOR SAFER DESIGNS OF CORONAVIRUS VACCINES | JADHAO, SAMADHAN JAISING | 1672 | §101§103§112 | Non-Final OA | — | Pending | Sep 06, 2023 |
| 18280283 | System and Method for Tracking an Object Based on Skin Images | BRUCE, FAROUK A | 3797 | §103 | Non-Final OA | 48d | Pending | Sep 05, 2023 |
| 18548875 | SYSTEM AND METHOD FOR ASSESSMENT OF STROKE PATIENTS AND PERSONALIZED REHABILITATION | ABOUELELA, MAY A | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18454646 | FAT-ASSOCIATED LYMPHOID CLUSTERS AS SITES FOR TRANSPLANTATION, TISSUE REGENERATION, ORGANOGENESIS AND FUNCTION FOR MULTIPLE TISSUES | CONNORS, ALEXANDRA F | 1634 | DP | Final Rejection | — | Pending | Aug 23, 2023 |
| 18277765 | SMALL MOLECULE ALLOSTERIC MODULATORS OF CLASS B GPCR, THE PTHR, AND METHOD TO IDENTIFY THEM | MOORE, SUSANNA | 1624 | §103 | Final Rejection | 36d overdue | Pending | Aug 17, 2023 |
| 18342884 | PEPTIDE ANALOGS CAPABLE OF ENHANCING STIMULATION OF A GLIOMA-SPECIFIC CTL RESPONSE | REDDIG, PETER J | 1646 | Other | Non-Final OA | 5d | Pending | Jun 28, 2023 |
| 18331607 | Targeted Gene Therapies for Pain and Other Neuro-Related Disorders | WEIDNER, ADAM M | 1675 | §112DP | Final Rejection | — | Pending | Jun 08, 2023 |
| 18316001 | Artificial Cells and Delivery Devices for Use in Tissue Engineering, and Related Methods | FOX, ALLISON M | — | §102§103DP | Non-Final OA | — | Pending | May 11, 2023 |
| 18031721 | IMPLANTABLE DEVICES WITH ANTIBACTERIAL COATING | OU, JING RUI | 3771 | §102§103 | Non-Final OA | — | Pending | Apr 13, 2023 |
| 18027575 | INTERPOSITIONAL IMPLANT FOR GROWTH PLATE INJURY | HOLT, ANDRIAE M | 1614 | §102§103§112DP | Non-Final OA | — | Pending | Mar 21, 2023 |
| 18245936 | System and Method for Operating a Ventilator | GONG, KRIS HANYU | 3785 | §103 | Non-Final OA | — | Pending | Mar 20, 2023 |
| 18026041 | BIOCARPET: A LOW PROFILE, MECHANICALLY OPTIMIZED, AND FULLY BIODEGRADABLE ENDOVASCULAR DEVICE FOR TREATMENT OF PERIPHERAL VASCULAR DISEASES | FREAY, CHARLES GRANT | 3746 | §103§112 | Non-Final OA | — | Pending | Mar 13, 2023 |
| 18094535 | ENDOVASCULAR APPARATUS FOR PERFUSING ORGANS IN A BODY | WIEST, PHILIP R | 3781 | §102§103DP | Final Rejection | 7d | Pending | Jan 09, 2023 |
| 18013951 | Electrochemical Biosensors for Rapid and Sensitive Detection of Pathogens and Pathogenic Biomarkers | KAUR, GURPREET | 1759 | §103§112 | Non-Final OA | 7d | Pending | Dec 30, 2022 |
| 17927548 | Adenovirus-Based SARS-CoV-2 Vaccine | ALLEN, MICHAEL D | 1671 | §103§112Other | Final Rejection | 3d overdue | Pending | Nov 23, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Pittsburgh has 93 pending office actions as of October 2026, spread across 47 art units and 89 examiners.
Allison M Fox has the most, with 2 of University of Pittsburgh's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.